Elma Research Limited 08711641 false 2025-01-01 2025-12-31 2025-12-31 The principal activity of the company is providing qualitative market research to pharmaceuticals and other businesses. Digita Accounts Production Advanced 6.30.9574.0 true false true 08711641 2025-01-01 2025-12-31 08711641 2025-12-31 08711641 bus:Director4 2025-12-31 08711641 bus:Director5 2025-12-31 08711641 core:RetainedEarningsAccumulatedLosses 2025-12-31 08711641 core:ShareCapital 2025-12-31 08711641 core:CurrentFinancialInstruments 2025-12-31 08711641 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 08711641 core:OfficeEquipment 2025-12-31 08711641 core:OtherPropertyPlantEquipment 2025-12-31 08711641 bus:SmallEntities 2025-01-01 2025-12-31 08711641 bus:Audited 2025-01-01 2025-12-31 08711641 bus:FilletedAccounts 2025-01-01 2025-12-31 08711641 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 08711641 bus:RegisteredOffice 2025-01-01 2025-12-31 08711641 bus:Director2 2025-01-01 2025-12-31 08711641 bus:Director4 2025-01-01 2025-12-31 08711641 bus:Director5 2025-01-01 2025-12-31 08711641 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 08711641 bus:Agent1 2025-01-01 2025-12-31 08711641 core:OfficeEquipment 2025-01-01 2025-12-31 08711641 core:OtherPropertyPlantEquipment 2025-01-01 2025-12-31 08711641 core:PlantMachinery 2025-01-01 2025-12-31 08711641 core:OtherRelatedParties 2025-01-01 2025-12-31 08711641 1 2025-01-01 2025-12-31 08711641 countries:AllCountries 2025-01-01 2025-12-31 08711641 2024-12-31 08711641 core:OfficeEquipment 2024-12-31 08711641 core:OtherPropertyPlantEquipment 2024-12-31 08711641 2024-01-01 2024-12-31 08711641 2024-12-31 08711641 core:RetainedEarningsAccumulatedLosses 2024-12-31 08711641 core:ShareCapital 2024-12-31 08711641 core:CurrentFinancialInstruments 2024-12-31 08711641 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 08711641 core:OfficeEquipment 2024-12-31 08711641 core:OtherPropertyPlantEquipment 2024-12-31 iso4217:GBP xbrli:pure

Registration number: 08711641

Elma Research Limited

Filleted Financial Statements

for the Year Ended 31 December 2025

 

Elma Research Limited

Contents

Company Information

1

Director's Report

2

Balance Sheet

3

Notes to the Financial Statements

4 to 8

 

Elma Research Limited

Company Information

Director

M Massagrande

S Catargiu
 

Registered office

3 Waterhouse Square
138-142 Holborn
London
EC1N 2SW

Auditors

DTL Auditors Ltd 5th Floor, North Side
7/10 Chandos Street
London
W1G 9DQ

 

Elma Research Limited

Director's Report for the Year Ended 31 December 2025

The director presents his report and the financial statements for the year ended 31 December 2025.

Directors of the company

The directors who held office during the year were as follows:

M Massagrande

N R Hogan (ceased 8 July 2025)

G S Quy (ceased 8 July 2025)

S Catargiu was appointed on 8 July 2025

Principal activity

The principal activity of the company is providing qualitative market research to pharmaceuticals and other businesses.

Disclosure of information to the auditors

The director has taken steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the company's auditors are aware of that information. The director confirms that there is no relevant information that he knows of and of which he knows the auditors are unaware.

Small companies provision statement

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the director on 2 September 2026
 

.........................................
M Massagrande
Director

 

Elma Research Limited

(Registration number: 08711641)
Balance Sheet as at 31 December 2025

Note

2025
£

2024
£

Fixed assets

 

Tangible assets

5

6,959

9,563

Current assets

 

Debtors

6

761,452

1,019,686

Cash at bank and in hand

 

78,929

352,263

 

840,381

1,371,949

Creditors: Amounts falling due within one year

7

(837,109)

(1,066,146)

Net current assets

 

3,272

305,803

Net assets

 

10,231

315,366

Capital and reserves

 

Called up share capital

1,000

1,000

Retained earnings

9,231

314,366

Shareholders' funds

 

10,231

315,366

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account and Director's Report.

Approved and authorised by the director on 2 September 2026
 

.........................................
M Massagrande
Director

 

Elma Research Limited

Notes to the Financial Statements for the Year Ended 31 December 2025

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
3 Waterhouse Square
138-142 Holborn
London
EC1N 2SW
England

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Audit report

The Independent Auditor's Report was unqualified.

The name of the Senior Statutory Auditor who signed the audit report on 4 September 2026 was John Tiltman, who signed for and on behalf of DTL Auditors Ltd.

.........................................

Revenue recognition

Turnover is measured at the fair value of the consideration received or receivable net of VAT and trade discounts.

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract.

 

Elma Research Limited

Notes to the Financial Statements for the Year Ended 31 December 2025

Accrued Income and accrued related costs

Accrued income and the accrued related costs are included in the financial statements where more than 85% of the fieldwork has been carried out by the year end.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tax

The tax expense for the period comprises tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and machinery

20% straight line basis

Office equipment

20% straight line basis

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

 

Elma Research Limited

Notes to the Financial Statements for the Year Ended 31 December 2025

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

Financial instruments

Classification
The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors,loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares.
 Recognition and measurement
Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective impairment is found, an impairment loss is recognised in Profit or Loss Account.

Financial assets and liabilities are offset and the net amount reported in the Balance Sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

 

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 11 (2024 - 15).

 

Elma Research Limited

Notes to the Financial Statements for the Year Ended 31 December 2025

4

Loss before tax

Arrived at after charging/(crediting)

2025
£

2024
£

Depreciation expense

4,586

5,798

Foreign currency (gains)/losses - operating expense

19,676

49,554

5

Tangible assets

Office equipment
£

Other tangible assets
 £

Total
£

Cost or valuation

At 1 January 2025

15,832

28,788

44,620

Additions

1,981

-

1,981

Disposals

-

(699)

(699)

At 31 December 2025

17,813

28,089

45,902

Depreciation

At 1 January 2025

7,899

27,157

35,056

Charge for the year

2,955

1,631

4,586

Eliminated on disposal

-

(699)

(699)

At 31 December 2025

10,854

28,089

38,943

Carrying amount

At 31 December 2025

6,959

-

6,959

At 31 December 2024

7,933

1,630

9,563

 

Elma Research Limited

Notes to the Financial Statements for the Year Ended 31 December 2025

6

Debtors

Current

2025
£

2024
£

Trade debtors

672,632

857,155

Prepayments

24,352

44,732

Other debtors

64,468

117,799

 

761,452

1,019,686

7

Creditors

Creditors: amounts falling due within one year

Note

2025
£

2024
£

Due within one year

 

Trade creditors

 

94,352

129,234

Amounts owed to group undertakings and undertakings in which the company has a participating interest

8

397,539

248,702

Taxation and social security

 

11,532

17,419

Accruals and deferred income

 

328,155

662,097

Other creditors

 

5,531

8,694

 

837,109

1,066,146

8

Related party transactions

Summary of transactions with other related parties

During the year, the company provided market research services to its parent company, Elma Research Srl for:£17,456 (2024: £29,286).

The company also received services from its parent and charges recognised during the year in respect of these services amounted to £312,069 (2024: 293,171) which have been included within direct and subcontractor costs.

At the period end the net balance due to the parent company was £397,539 (2024: £248,702) and is interest free and payable on demand.

.

9

Parent and ultimate parent undertaking

The company's immediate parent is Elma Research SRL, incorporated in Italy.